查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1908648

gRNA市场规模、份额和趋势分析报告：按产品/服务、gRNA类型、应用、最终用途、地区和细分市场预测（2025-2033年）

gRNA Market Size, Share & Trends Analysis Report By Product & Service (Products, Custom gRNA Synthesis Services), By gRNA Type (Research-use, GPM-grade), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

gRNA市场概况

2024年全球gRNA市场规模估计为5.795亿美元，预计2033年将达到26.6亿美元。

预计从 2025 年到 2033 年，gRNA 将以 18.64% 的复合年增长率成长。由于 gRNA 是基于 CRISPR 的基因编辑所必需的，因此需求量很大。

将 CRISPR 系统精确靶向特定 DNA 序列的能力，能够实现精确的基因改造，从而推动医学、农业和生物技术领域的突破。

CRISPR基因编辑技术的应用范围不断扩大

从科学研究到工业，CRISPR应用范围的快速扩展正推动全球对gRNA的需求激增。作为将CRISPR靶向特定DNA或RNA的关键组成部分，所有CRISPR工作流程都依赖精准可靠的gRNA。 CRISPR在功能基因组学、基因敲除/敲入研究、基因修饰细胞模型和高通量筛检等领域的日益广泛应用，显着推动了客製化gRNA消费量的成长。随着CRISPR技术从科学研究走向临床和治疗应用，尤其是在基因治疗和精准医疗领域，越来越多的生物製药公司和学术实验室开始采用这项技术，进一步增加了对专用gRNA的需求。例如，2021年10月，德国默克公司将其取得专利的CRISPR-Cas9技术授权给Cellecta公司，从而推动了先进的基因敲入应用。

CRISPR系统的日益多样化推动了对客製化gRNA产品的需求。随着基因编辑技术从传统的Cas9发展到用于RNA标靶化和小型化递送的下一代工具（如Cas12和Cas13），以及碱基编辑和先导编辑等​​平台，研究人员需要高效且脱靶效应最小的最佳化gRNA。

目录

第一章调查方法和范围

第二章：gRNA市场：执行摘要

  • 市场展望
  • 细分市场概览
  • 竞争格局概述

第三章 gRNA市场变数和趋势

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关及辅助市场展望
  • 市场动态
  • 市场驱动因素分析
    • CRISPR基因编辑技术的应用范围不断扩大
    • 扩大蛋白质体学和基因组学领域的研究与开发
  • 市场限制因素分析
    • 监管挑战
    • 脱靶效应与安全性问题
  • 商业环境分析
    • 波特五力分析
    • PESTLE分析

第四章：按产品和服务分類的估算和趋势分析

  • gRNA市场：按产品和服务分類的差异分析
  • 产品
    • 产品市场估算与预测，2021-2033年
    • 最终产品
    • gRNA合成产物
  • 客製化gRNA合成服务
    • 客製化gRNA合成服务市场估算与预测，2021-2033年

第五章 按gRNA类型进行的估计和趋势分析

  • gRNA市场：按gRNA类型分類的差异分析
  • 研究用途
    • 研究应用市场收入估计与预测，2021-2033年
  • GMP级
    • GMP级产品市场收入估算及预测，2021-2033年

第六章 应用估算与趋势分析

  • gRNA市场：按应用分類的差异分析
  • 基因组工程
    • 基因组工程市场收入估算与预测，2021-2033年
  • 疾病模型研究
    • 疾病建模研究市场收入估算与预测，2021-2033年
  • 功能基因体学
    • 功能基因体学市场收入估计与预测，2021-2033年
  • 表观遗传学
    • 表观遗传学市场收入估算与预测，2021-2033年
  • 其他的
    • 其他市场收入估算与预测，2021-2033年

第七章 依最终用途估算与趋势分析

  • gRNA市场：依最终用途分類的差异分析
  • 製药和生物技术公司
    • 2021-2033年医药和生物技术市场收入估计和预测
  • 学术研究机构
    • 学术研究机构市场收入估算与预测，2021-2033年
  • 合约生产组织 (CMO) 和合约研究组织 (CRO)
    • 2021-2033年CMO和CRO市场收入估算与预测

第八章：区域商业分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 北美gRNA市场估算与预测，2021-2033年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 欧洲 gRNA 市场，2021-2033
    • 英国
    • 德国
    • 西班牙
    • 法国
    • 义大利
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太地区gRNA市场，2021-2033年
    • 日本
    • 中国
    • 印度
    • 韩国
    • 泰国
    • 澳洲
  • 拉丁美洲
    • 2021-2033年拉丁美洲gRNA市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2021-2033年中东及非洲gRNA市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争情势

  • 公司分类
  • 策略规划
  • 2024年市场分析
  • 公司简介
    • Thermo Fisher Scientific, Inc
    • Agilent Technologies, Inc.
    • System Biosciences, LLC.
    • Jena Bioscience GmbH
    • Merck KGaA
    • Azenta Life Sciences（Genewiz）
    • Takara Bio Inc.
    • Synbio Technologies
    • Revvity Inc（Horizon Discovery Ltd.）
    • Synthego
Product Code: GVR-4-68040-180-5

gRNA Market Summary

The global gRNA market size was estimated at USD 579.5 million in 2024 and is projected to reach USD 2.66 billion by 2033, growing at a CAGR of 18.64% from 2025 to 2033. gRNA is in high demand because it is essential for CRISPR-based genetic editing.

Its ability to accurately guide the CRISPR system to specific DNA sequences enables precise gene modifications, driving breakthroughs in medicine, agriculture, and biotechnology.

Expansion of CRISPR Gene Editing Applications

The global demand for gRNA is rising sharply due to the rapid expansion of CRISPR applications across research and industry. As the critical element that directs CRISPR to specific DNA or RNA targets, every CRISPR workflow depends on precise and reliable gRNA. Increasing use of CRISPR in functional genomics, knockout/knock-in studies, engineered cell models, and high-throughput screening has driven strong growth in customized gRNA consumption. With CRISPR advancing from research to clinical and therapeutic applications, especially in gene therapy and precision medicine, more biopharma and academic labs are adopting the technology, further escalating the need for specialized gRNA. For instance, in October 2021, in Germany, Merck licensed its patented CRISPR-Cas9 technology to Cellecta, enabling advanced knock-in applications.

The growing diversification of CRISPR systems is further boosting demand for tailored gRNA products. As gene-editing advances from traditional Cas9 to next-generation tools like Cas12 and Cas13 for RNA targeting, for compact delivery, and platforms such as base and prime editing, researchers require highly optimized gRNAs with greater efficiency and minimal off-target effects.

Global gRNA Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global gRNA market report based on product & services, gRNA type, application, end-use, and region:

  • Product & Service Outlook (Revenue in USD Million, 2021 - 2033)
  • Products
    • gRNA Final Products
    • gRNA Synthesis Products
    • gRNA Synthesis Kits
    • Plasmids
    • Others
  • Custom gRNA Synthesis Services
  • gRNA Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Research-Use
  • GMP-grade
  • Application Outlook (Revenue, USD Million; 2021 - 2033)
  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others
  • End-use Outlook (Revenue, USD Million; 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • CMOs & CROs
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Service
    • 1.2.2. gRNA Type
    • 1.2.3. Application
    • 1.2.4. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. gRNA Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. gRNA Market Variables and Trends

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Expansion of CRISPR gene editing applications
    • 3.4.2. Growing R&D in proteomics and genomics
  • 3.5. Market Restraint Analysis
    • 3.5.1. Regulatory Challenges
    • 3.5.2. Off-Target Effects and Safety Concerns
  • 3.6. Business Environment Analysis
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTLE Analysis

Chapter 4. Product & Service Estimates & Trend Analysis

  • 4.1. Product & Service Segment Dashboard
  • 4.2. gRNA market: Product & Service Movement Analysis
  • 4.3. Products
    • 4.3.1. Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. gRNA Final Products
      • 4.3.2.1. gRNA Final Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. gRNA Synthesis Products
      • 4.3.3.1. gRNA Synthesis Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. gRNA Synthesis Kits
        • 4.3.3.2.1. gRNA Synthesis Kits Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Plasmids
        • 4.3.3.3.1. Plasmids Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.4. Others
        • 4.3.3.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Custom gRNA Synthesis Services
    • 4.4.1. Custom gRNA Synthesis Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. gRNA Type Estimates & Trend Analysis

  • 5.1. gRNA Type Segment Dashboard
  • 5.2. gRNA market: gRNA Type Movement Analysis
  • 5.3. Research-Use
    • 5.3.1. Research-Use Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. GMP-grade
    • 5.4.1. GMP-grade Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. gRNA market: Application Movement Analysis
  • 6.3. Genome Engineering
    • 6.3.1. Genome Engineering Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Disease Model Studies
    • 6.4.1. Disease Model Studies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Functional Genomics
    • 6.5.1. Functional Genomics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Epigenetics
    • 6.6.1. Epigenetics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. End Use Estimates & Trend Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. gRNA market: End-Use Movement Analysis
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Academic Research Institutes
    • 7.4.1. Academic Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. CMOs & CROs
    • 7.5.1. CMOs & CROs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.4. North America
    • 8.4.1. North America gRNA Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. U.S. gRNA Market, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. Canada gRNA Market, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Target Disease Prevalence
      • 8.4.4.5. Mexico gRNA Market, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. UK gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Germany gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.4. Spain
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. Spain gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.5. France
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. France gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.6. Italy
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Target Disease Prevalence
      • 8.5.6.5. Italy gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Target Disease Prevalence
      • 8.5.7.5. Denmark gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Target Disease Prevalence
      • 8.5.8.5. Sweden gRNA Market, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Target Disease Prevalence
      • 8.5.9.5. Norway gRNA Market, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia-Pacific gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Target Disease Prevalence
      • 8.6.2.5. Japan gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Target Disease Prevalence
      • 8.6.3.5. China gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Target Disease Prevalence
      • 8.6.4.5. India gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Target Disease Prevalence
      • 8.6.5.5. South Korea gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.6. Thailand
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Target Disease Prevalence
      • 8.6.6.5. Thailand gRNA Market, 2021 - 2033 (USD Million)
    • 8.6.7. Australia
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Target Disease Prevalence
      • 8.6.7.5. Australia gRNA Market, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America gRNA Market, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Target Disease Prevalence
      • 8.7.2.5. Brazil gRNA Market, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Target Disease Prevalence
      • 8.7.3.5. Argentina gRNA Market, 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA gRNA Market, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Target Disease Prevalence
      • 8.8.2.5. South Africa gRNA Market, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Target Disease Prevalence
      • 8.8.3.5. Saudi Arabia gRNA Market, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Target Disease Prevalence
      • 8.8.4.5. UAE gRNA Market, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Target Disease Prevalence
      • 8.8.5.5. Kuwait gRNA Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Market Position Analysis, 2024
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. Agilent Technologies, Inc.
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. System Biosciences, LLC.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Jena Bioscience GmbH
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Merck KGaA
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Azenta Life Sciences (Genewiz)
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Benchmarking
      • 9.4.6.3. Strategic Initiatives
    • 9.4.7. Takara Bio Inc.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Synbio Technologies
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Revvity Inc (Horizon Discovery Ltd.)
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Synthego
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Market Research Process
  • TABLE 2 Information Procurement
  • TABLE 3 Primary Research Pattern
  • TABLE 4 Market Research Approaches
  • TABLE 5 Value Chain-Based Sizing & Forecasting
  • TABLE 6 Market Formulation & Validation
  • TABLE 7 gRNA market Segmentation
  • TABLE 8 Market Snapshot, 2024
  • TABLE 9 Market Trends & Outlook
  • TABLE 10 Market Driver Relevance Analysis (Current & Future Impact)
  • TABLE 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • TABLE 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • TABLE 13 Porter's Five Forces Analysis
  • TABLE 14 Global gRNA market: Product & Service Movement Analysis
  • TABLE 15 Global gRNA market, for Products, 2021 - 2033 (USD Million)
  • TABLE 16 Global gRNA market, for gRNA Final Products, 2021 - 2033 (USD Million)
  • TABLE 17 Global gRNA market, for gRNA Synthesis Products, 2021 - 2033 (USD Million)
  • TABLE 18 Global gRNA market, for gRNA Synthesis Kits, 2021 - 2033 (USD Million)
  • TABLE 19 Global gRNA market, for Plasmids, 2021 - 2033 (USD Million)
  • TABLE 20 Global gRNA market, for Others, 2021 - 2033 (USD Million)
  • TABLE 21 Global gRNA market, for Custom gRNA Synthesis Services, 2021 - 2033 (USD Million)
  • TABLE 22 Global gRNA market: gRNA Type Movement Analysis
  • TABLE 23 Global gRNA market, for Research-Use, 2021 - 2033 (USD Million)
  • TABLE 24 Global gRNA market, for GMP-grade, 2021 - 2033 (USD Million)
  • TABLE 25 Global gRNA market: Application Movement Analysis
  • TABLE 26 Global gRNA market, for Genome Engineering, 2021 - 2033 (USD Million)
  • TABLE 27 Global gRNA market, for Disease Model Studies, 2021 - 2033 (USD Million)
  • TABLE 28 Global gRNA market, for Functional Genomics, 2021 - 2033 (USD Million)
  • TABLE 29 Global gRNA market, for Epigenetics, 2021 - 2033 (USD Million)
  • TABLE 30 Global gRNA market, for Others, 2021 - 2033 (USD Million)
  • TABLE 31 Global gRNA market: End Use Movement Analysis
  • TABLE 32 Global gRNA market, for Pharmaceutical & Biotechnology Companies, 2021 - 2033 (USD Million)
  • TABLE 33 Global gRNA market, for Academic Research Institutes, 2021 - 2033 (USD Million)
  • TABLE 34 Global gRNA market, for CMOs & CROs, 2021 - 2033 (USD Million)
  • TABLE 35 Regional Marketplace: Key Takeaways
  • TABLE 36 Regional Outlook, 2023 & 2033
  • TABLE 37 Global gRNA market: Region Movement Analysis
  • TABLE 38 North America gRNA market, 2021 - 2033 (USD Million)
  • TABLE 39 U.S. gRNA market, 2021 - 2033 (USD Million)
  • TABLE 40 Canada gRNA market, 2021 - 2033 (USD Million)
  • TABLE 41 Mexico gRNA market, 2021 - 2033 (USD Million)
  • TABLE 42 Europe gRNA market, 2021 - 2033 (USD Million)
  • TABLE 43 Germany gRNA market, 2021 - 2033 (USD Million)
  • TABLE 44 UK gRNA market, 2021 - 2033 (USD Million)
  • TABLE 45 France gRNA market, 2021 - 2033 (USD Million)
  • TABLE 46 Italy gRNA market, 2021 - 2033 (USD Million)
  • TABLE 47 Spain gRNA market, 2021 - 2033 (USD Million)
  • TABLE 48 Denmark gRNA market, 2021 - 2033 (USD Million)
  • TABLE 49 Sweden gRNA market, 2021 - 2033 (USD Million)
  • TABLE 50 Norway gRNA market, 2021 - 2033 (USD Million)
  • TABLE 51 Asia Pacific gRNA market, 2021 - 2033 (USD Million)
  • TABLE 52 Japan gRNA market, 2021 - 2033 (USD Million)
  • TABLE 53 China gRNA market, 2021 - 2033 (USD Million)
  • TABLE 54 India gRNA market, 2021 - 2033 (USD Million)
  • TABLE 55 Australia gRNA market, 2021 - 2033 (USD Million)
  • TABLE 56 South Korea gRNA market, 2021 - 2033 (USD Million)
  • TABLE 57 Thailand gRNA market, 2021 - 2033 (USD Million)
  • TABLE 58 Latin America gRNA market, 2021 - 2033 (USD Million)
  • TABLE 59 Brazil gRNA market, 2021 - 2033 (USD Million)
  • TABLE 60 Argentina gRNA market, 2021 - 2033 (USD Million)
  • TABLE 61 Middle East and Africa gRNA market, 2021 - 2033 (USD Million)
  • TABLE 62 South Africa gRNA market, 2021 - 2033 (USD Million)
  • TABLE 63 Saudi Arabia gRNA market, 2021 - 2033 (USD Million)
  • TABLE 64 UAE gRNA market, 2021 - 2033 (USD Million)
  • TABLE 65 Kuwait gRNA market, 2021 - 2033 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Market formulation & validation
  • FIG. 4 gRNA market: Market outlook
  • FIG. 5 gRNA market: Segment outlook
  • FIG. 6 gRNA market: Competitive landscape outlook
  • FIG. 7 Parent market outlook
  • FIG. 8 gRNA market driver impact
  • FIG. 9 gRNA market restraint impact
  • FIG. 10 gRNA market: Product & Service outlook and key takeaways
  • FIG. 11 gRNA market: Product & Service movement analysis
  • FIG. 12 Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 13 gRNA Final Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 14 gRNA Synthesis Products market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 15 gRNA Synthesis Kits market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 16 Plasmids market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 17 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 18 Custom gRNA Synthesis Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 19 gRNA market: gRNA Type outlook and key takeaways
  • FIG. 20 gRNA market: gRNA Type movement analysis
  • FIG. 21 Research-Use market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 22 GMP-grade market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 23 gRNA market: Application outlook and key takeaways
  • FIG. 24 gRNA market: Application movement analysis
  • FIG. 25 Genome Engineering market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 26 Disease Model Studies market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 27 Functional Genomics market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 28 Epigenetics market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 29 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 30 gRNA market: End use outlook and key takeaways
  • FIG. 31 gRNA market: End use movement analysis
  • FIG. 32 Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 33 Pharmaceutical & biotechnology companies market estimates and forecasts,2021 - 2033 (USD Million)
  • FIG. 34 CMOs & CROs market estimates and forecasts,2021 - 2033 (USD Million)
  • FIG. 35 Global gRNA market: Regional outlook and key takeaways
  • FIG. 36 Global gRNA market: Regional movement analysis
  • FIG. 37 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 38 Key country dynamics
  • FIG. 39 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 40 Key country dynamics
  • FIG. 41 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 42 Key country dynamics
  • FIG. 43 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 44 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 45 Key country dynamics
  • FIG. 46 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 47 Key country dynamics
  • FIG. 48 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 49 Key country dynamics
  • FIG. 50 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 51 Key country dynamics
  • FIG. 52 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 53 Key country dynamics
  • FIG. 54 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 55 Key country dynamics
  • FIG. 56 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 57 Key country dynamics
  • FIG. 58 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 59 Key country dynamics
  • FIG. 60 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 61 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 62 Key country dynamics
  • FIG. 63 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 64 Key country dynamics
  • FIG. 65 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 66 Key country dynamics
  • FIG. 67 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 68 Key country dynamics
  • FIG. 69 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 70 Key country dynamics
  • FIG. 71 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 72 Key country dynamics
  • FIG. 73 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 74 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 75 Key country dynamics
  • FIG. 76 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 77 Key country dynamics
  • FIG. 78 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 79 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 80 Key country dynamics
  • FIG. 81 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 82 Key country dynamics
  • FIG. 83 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 84 Key country dynamics
  • FIG. 85 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • FIG. 86 Key country dynamics
  • FIG. 87 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)